KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Share-based Compensation (2016 - 2025)

Rigel Pharmaceuticals has reported Share-based Compensation over the past 16 years, most recently at $2.7 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 31.67% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $12.7 million, up 2.57%, while the annual FY2025 figure was $12.7 million, 2.57% up from the prior year.
  • Share-based Compensation for Q4 2025 was $2.7 million at Rigel Pharmaceuticals, down from $3.4 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $5.1 million in Q1 2024 and troughed at $1.9 million in Q4 2023.
  • A 5-year average of $2.8 million and a median of $2.6 million in 2021 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: plummeted 52.62% in 2023 and later skyrocketed 86.15% in 2024.
  • Year by year, Share-based Compensation stood at $2.3 million in 2021, then soared by 74.43% to $4.1 million in 2022, then plummeted by 52.62% to $1.9 million in 2023, then grew by 7.97% to $2.1 million in 2024, then surged by 31.67% to $2.7 million in 2025.
  • Business Quant data shows Share-based Compensation for RIGL at $2.7 million in Q4 2025, $3.4 million in Q3 2025, and $3.3 million in Q2 2025.